Literature DB >> 8014694

Hypoglycemia in normal neonates appropriate for gestational age.

M D Cole1, K Peevy.   

Abstract

A prospective study was performed to compare the frequency of hypoglycemia in normal neonates appropriate for gestational age delivered by cesarean section and neonates delivered by normal vaginal deliveries (n = 60). Intrapartal and prenatal risk factors were recorded. A cord glucose reading and a glucose reading within the first 2 hours of age were analyzed. Hypoglycemia was defined as a blood glucose level of < 40 mg/dl in a neonate. The study disclosed a 43% incidence of hypoglycemia in neonates delivered by cesarean section and a 37% incidence in neonates delivered vaginally. Neonates who were black, male, or both had a higher incidence of hypoglycemia. Other prenatal or intrapartal factors were not significantly associated with the development of hypoglycemia. The incidence of hypoglycemia in this study was much higher than in previous studies of neonates appropriate for gestational age that were performed before conduction anesthesia was widely used. Further studies should evaluate the possible impact of perinatal anesthesia on the development of transient neonatal hypoglycemia.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8014694

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  9 in total

1.  Two hour blood glucose levels in at-risk babies: An audit of Canadian guidelines.

Authors:  Jennifer Croke; Meagan Sullivan; Anne Ryan-Drover; Ed Randell; Wayne Andrews; Khalid Aziz
Journal:  Paediatr Child Health       Date:  2009-04       Impact factor: 2.253

2.  Standards of admission capillary blood glucose levels in cesarean born neonates.

Authors:  Tatiana Smolkin; Irena Ulanovsky; Pnina Carasso; Imad R Makhoul
Journal:  World J Pediatr       Date:  2017-02-14       Impact factor: 2.764

3.  Blood glucose levels in a population of healthy, breast fed, term infants of appropriate size for gestational age.

Authors:  E Hoseth; A Joergensen; F Ebbesen; M Moeller
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-09       Impact factor: 5.747

4.  Randomised controlled trial of effect of terbutaline before elective caesarean section on postnatal respiration and glucose homeostasis.

Authors:  G Eisler; R Hjertberg; H Lagercrantz
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-03       Impact factor: 5.747

5.  Hypoglycaemia and hypocalcaemia as determinants of admission birth weight criteria for term stable low risk macrosomic neonates.

Authors:  Victor L Bandika; Fred N Were; Eseli D Simiyu; Donald P Oyatsi
Journal:  Afr Health Sci       Date:  2014-09       Impact factor: 0.927

6.  ABM clinical protocol #1: guidelines for blood glucose monitoring and treatment of hypoglycemia in term and late-preterm neonates, revised 2014.

Authors:  Nancy Wight; Kathleen A Marinelli
Journal:  Breastfeed Med       Date:  2014-05       Impact factor: 1.817

7.  Prevalence and factors associated with neonatal hypoglycemia in Northern Uganda: a community-based cross-sectional study.

Authors:  David Mukunya; Beatrice Odongkara; Thereza Piloya; Victoria Nankabirwa; Vincentina Achora; Charles Batte; James Ditai; Thorkild Tylleskar; Grace Ndeezi; Sarah Kiguli; James K Tumwine
Journal:  Trop Med Health       Date:  2020-11-04

8.  Neonatal hypoglycemia and the CPT1A P479L variant in term newborns: A retrospective cohort study of Inuit newborns from Kivalliq Nunavut.

Authors:  Sorcha A Collins; Gertrude Elizabeth Hildes-Ripstein; James Robert Thompson; Sharon Edmunds; Amber Miners; Cheryl Rockman-Greenberg; Laura Arbour
Journal:  Paediatr Child Health       Date:  2020-04-03       Impact factor: 2.253

9.  Association of maternal nutrition with transient neonatal hyperinsulinism.

Authors:  Mathilde Louvigne; Stephanie Rouleau; Emmanuelle Caldagues; Isabelle Souto; Yanis Montcho; Audrey Migraine Bouvagnet; Olivier Baud; Jean Claude Carel; Geraldine Gascoin; Regis Coutant
Journal:  PLoS One       Date:  2018-05-03       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.